Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Nu Skin Raises $210M From Chinese Investors; Shares Up

Published 06/15/2016, 09:00 PM
Updated 07/09/2023, 06:31 AM

Shares of Nu Skin Enterprises Inc. (NYSE:NUS) rose 4.45% in after-market trading on Jun 15 after the retailer agreed to take a $210 million investment from a Chinese consortium of investors, in order to accelerate growth in China.

The consortium is led by Ping An Securities Ltd., which is owned by Ping An of China Securities (Hong Kong) Company Ltd. and a group of additional investors affiliated with ZQ Capital Limited.

Under the terms of the investment, Ping An ZQ China Growth Limited is purchasing $210 million in aggregate principal amount of 4.75%, four-year convertible senior notes. Nu Skin expects to complete the sale of the notes within five business days, subject to customary closing conditions.

NU SKIN ENTERP Price and Consensus

NU SKIN ENTERP Price and Consensus | NU SKIN ENTERP Quote

Nu Skin plans to utilize the proceeds for repurchasing shares throughout the remainder of the year and invest in its China operations. As a result, this investment will be accretive for Nu Skin shareholders. The company will also benefit from investors’ in depth knowledge of the market and their expertise, which will help the company to grow over the long term.

As a result, the company now anticipates second quarter revenues to be at the high end of the previous guidance of $560 to $580 million, announced during the first quarter conference call. Also during the first quarter call, the company stated that it expects revenues to increase in a range of 6% to 8% on a constant currency basis, with earnings in the range of 75 – 79 cents per share in the second quarter. The Zacks Consensus Estimate of 81 cents per share is above the guided range. The company anticipates second quarter and 2016 gross margin to normalize and be above 78%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Nu Skin, a direct-sales beauty products and dietary supplements company, reported better-than-expected results in the first quarter of 2016. However, the results were significantly lower than the prior year due to margin declines. This skin care and nutritional products retailer raised its outlook for 2016 owing to new product launches and a favorable view on currency.

Nu Skin currently has a Zacks Rank #3 (Hold).

Stocks to Consider

A better-ranked stock in the same space is Estee Lauder Companies, Inc. (NYSE:EL) , with a Zacks Rank #2 (Buy). Stocks worth considering in the broader consumer staples sector include B&G Foods, Inc. (NYSE:BGS) and Post Holdings, Inc. (NYSE:POST) , both sporting a Zacks Rank #1 (Strong Buy).



NU SKIN ENTERP (NUS): Free Stock Analysis Report

ESTEE LAUDER (EL): Free Stock Analysis Report

B&G FOODS CL-A (BGS): Free Stock Analysis Report

POST HOLDINGS (POST): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.